Kathize Betti Lira
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Kathize Betti Lira has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Adriana Silveira Almeida
Postgraduate Program in Cardiothoracic Surgery, Nossa Senhora da Conceição Hospital, Porto Alegre, Brazil
2 shared publications - Alfeu Roberto Rombaldi
Department of Cardiothoracic Surgery, Nossa Senhora da Conceição Hospital, Porto Alegre, Brazil
2 shared publications - Fernando Anschau
Grupo Hospitalar Conceição Porto Alegre Brazil
2 shared publications - Juarez Rode
Postgraduate Program in Cardiothoracic Surgery, Nossa Senhora da Conceição Hospital, Porto Alegre, Brazil
2 shared publications - Rafael Antônio Widholzer Rey
Postgraduate Program in Cardiothoracic Surgery, Nossa Senhora da Conceição Hospital, Porto Alegre, Brazil
2 shared publications Alexsandro Rodrigues Oliveira
Department of Cardiothoracic Surgery, Division of Perfusion, Nossa Senhora da Conceição Hospital, Porto Alegre, Brazil
1 shared publication
Latest Publications
- Open Access
Comparison between three single-dose cardioplegic solutions in myocardial protection: Cardioplegia Trial – a double-blind randomised clinical trial
Objectives To compare myocardial protection afforded by three single-dose cardioplegic solutions — Custodiol (HTK), del Nido (DN) and modified del Nido (MDN) — in adult elective cardiac surgery. Design Double-blind randomised controlled trial. Setting Tertiary hospital in southern Brazil. Participants 99 adults undergoing elective valve or coronary artery bypass surgery with cardiopulmonary bypass. Interventions Administration of HTK, DN or MDN solution during surgery. Main outcome measures High-sensitivity cardiac troponin T (hs-cTnT) at 0, 2, 12 and 24 hours postoperatively. Additionally, indirect measures of myocardial protection were compared, both laboratory and clinical, during intraoperative and postoperative periods. Results All solutions provided effective myocardial protection, with similar clinical and laboratory outcomes. DN was associated with significantly lower hs-cTnT at 2 hours (p=0.023) and fewer intraoperative transfusions (p=0.008). HTK patients had lower postoperative sodium and potassium levels (p=0.049 and p=0.002, respectively). Survival and major postoperative outcomes, including vasoactive or mechanical support, were similar across groups. Conclusions The three cardioplegic strategies showed comparable biochemical profiles of myocardial injury. DN was associated with lower early troponin release and reduced transfusion requirements, while HTK produced transient electrolyte shifts. Trial registration number ReBEC; RBR-7g5s66.
Open AccessComparison between three single-dose cardioplegic solutions in myocardial protection: Cardioplegia Trial – a double-blind randomised clinical trial
Objectives To compare myocardial protection afforded by three single-dose cardioplegic solutions — Custodiol (HTK), del Nido (DN) and modified del Nido (MDN) — in adult elective cardiac surgery. Design Double-blind randomised controlled trial. Setting Tertiary hospital in southern Brazil. Participants 99 adults undergoing elective valve or coronary artery bypass surgery with cardiopulmonary bypass. Interventions Administration of HTK, DN or MDN solution during surgery. Main outcome measures High-sensitivity cardiac troponin T (hs-cTnT) at 0, 2, 12 and 24 hours postoperatively. Additionally, indirect measures of myocardial protection were compared, both laboratory and clinical, during intraoperative and postoperative periods. Results All solutions provided effective myocardial protection, with similar clinical and laboratory outcomes. DN was associated with significantly lower hs-cTnT at 2 hours (p=0.023) and fewer intraoperative transfusions (p=0.008). HTK patients had lower postoperative sodium and potassium levels (p=0.049 and p=0.002, respectively). Survival and major postoperative outcomes, including vasoactive or mechanical support, were similar across groups. Conclusions The three cardioplegic strategies showed comparable biochemical profiles of myocardial injury. DN was associated with lower early troponin release and reduced transfusion requirements, while HTK produced transient electrolyte shifts. Trial registration number ReBEC; RBR-7g5s66.
- Open Access
Comparison between Custodiol, del Nido and modified del Nido in the myocardial protection - Cardioplegia Trial: a study protocol for a randomised, double-blind clinical trial
Introduction Myocardial protection is essential for successful cardiac surgery, and the search for an ideal cardioplegic solution has continued since its beginning. In this context, Custodiol, del Nido and modified del Nido are single-dose cardioplegic solutions with good safety profiles and great relevance in modern surgical practice. While these solutions have all been evaluated for their impact on patient outcomes independently, limited research exists comparing them directly. Thus, the present study aims to examine the effects of these cardioplegic solutions on myocardial protection and clinical outcomes in adult patients undergoing elective cardiac surgery. The assessment of the increase in myocardial injury biomarkers in patients submitted to all treatment methods may be considered a major strength of our study. Methods and analysis This is a clinical trial study protocol that will compare myocardial protection and clinical outcomes among three patient groups based on which cardioplegic solution was used. Patients will be randomised to receive del Nido (n=30), modified del Nido (n=30) or Custodiol (n=30). Myocardial injury biomarkers will be measured at the baseline and 2 hours, 12 hours and 24 hours after the cardiopulmonary bypass. Clinical outcomes will be assessed during the trans operative period and the intensive care unit stay, in addition to other haematological parameters. Ethics and dissemination This protocol and its related documents were approved by the Research Ethics Committee of the Hospital Nossa Senhora da Conceição, Brazil, registered under no. 4.029.545. The findings of this study will be published in a peer-reviewed journal in the related field. Trial registration number RBR-7g5s66.
Open AccessComparison between Custodiol, del Nido and modified del Nido in the myocardial protection - Cardioplegia Trial: a study protocol for a randomised, double-blind clinical trial
Introduction Myocardial protection is essential for successful cardiac surgery, and the search for an ideal cardioplegic solution has continued since its beginning. In this context, Custodiol, del Nido and modified del Nido are single-dose cardioplegic solutions with good safety profiles and great relevance in modern surgical practice. While these solutions have all been evaluated for their impact on patient outcomes independently, limited research exists comparing them directly. Thus, the present study aims to examine the effects of these cardioplegic solutions on myocardial protection and clinical outcomes in adult patients undergoing elective cardiac surgery. The assessment of the increase in myocardial injury biomarkers in patients submitted to all treatment methods may be considered a major strength of our study. Methods and analysis This is a clinical trial study protocol that will compare myocardial protection and clinical outcomes among three patient groups based on which cardioplegic solution was used. Patients will be randomised to receive del Nido (n=30), modified del Nido (n=30) or Custodiol (n=30). Myocardial injury biomarkers will be measured at the baseline and 2 hours, 12 hours and 24 hours after the cardiopulmonary bypass. Clinical outcomes will be assessed during the trans operative period and the intensive care unit stay, in addition to other haematological parameters. Ethics and dissemination This protocol and its related documents were approved by the Research Ethics Committee of the Hospital Nossa Senhora da Conceição, Brazil, registered under no. 4.029.545. The findings of this study will be published in a peer-reviewed journal in the related field. Trial registration number RBR-7g5s66.